Amgen: Biotech Giant's Path to Growth and Recovery
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
Participate in financial planning workshops tailored for young adults. Gain the skills needed to secure your financial future.
17,930 articlesAmgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
Eli Lilly is shaking up its growth plan by expanding beyond obesity with new infectious disease initiatives. This art...
Berkshire Hathaway stands out as a core, set-it-and-forget-it holding as markets wobble in 2026. Its fortress balance...
SpaceX hits the Nasdaq in a historic IPO, drawing a diverse crowd of space enthusiasts and retail traders. The debut ...
Trump declares the U.S.-Iran peace deal complete, sending stock futures higher and oil prices fluctuating. Yet analys...
Standard Chartered unveils a bold UNI price forecast for 2030, arguing tokenized assets will push DeFi liquidity to t...
A large government check meant for a Brooklyn health care company became the center of a risk many people overlook. L...
Laurel Road, the digital banking brand backed by KeyBank, pairs student-loan refinancing with a high-yield savings op...
A frightened call claimed a loved one was in trouble, pushing for quick payment. She paused, verified, and saved thou...
Viking Therapeutics trades around the low $30s as pivotal data for VK2735 approaches. This article breaks down whethe...
The CLARITY Act moves to a July field hearing in New York, but final passage now hinges on seven Senate Democrats. An...
Shareholders allege a controlling investor pressured Red Lobster to endure an endless shrimp push, turning a popular ...